K234015 is an FDA 510(k) clearance for the Caphosol® Artifical Saliva (32 doses sachet box). Classified as Saliva, Artificial (product code LFD).
Submitted by Eusa Pharma (Uk) Limited (Hemel Hempstead, GB). The FDA issued a Cleared decision on March 11, 2024 after a review of 83 days - a notably fast clearance cycle.
This device falls under the Dental FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Eusa Pharma (Uk) Limited devices